Lexaria Bioscience Corp. — Director's Dealing 2025

May 16, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Lexaria Bioscience Corp. (LEXX)
CIK: 0001348362
Period of Report: 2025-05-15

Reporting Person: Carle Vanessa (Secretary)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-05-15	Stock Options	$1.04	A	15000	Acquired	2030-05-15	Common Shares (15000)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options	$3	2026-04-26	Common Shares (12500)	12500	Direct
Stock Options	$3	2026-06-08	Common Shares (5000)	17500	Direct
Stock Options	$3	2026-09-01	Common Shares (10000)	27500	Direct
Stock Options	$2.91	2027-08-29	Common Shares (12500)	40000	Direct
Stock Options	$1.15	2028-10-26	Common Shares (10000)	50000	Direct
Stock Options	$2.36	2029-04-26	Common Shares (10000)	60000	Direct